TABLE 5.
The analysis outcomes of FBG 08 in the low-dosage group in study 2.
Critical values (mmol/L) | Reached (n) | HbA1c012>0% (n) | Percentage (%) |
---|---|---|---|
0.1 | 44 | 40 | 90.9 a |
0.2 | 43 | 39 | 90.7 a |
0.3 | 40 | 36 | 90.0 a |
0.4 | 40 | 36 | 90.0 a |
0.5 | 37 | 33 | 89.2 a |
0.6 | 33 | 30 | 90.9 a |
0.7 | 32 | 30 | 93.8 a |
0.8 | 31 | 29 | 93.5 a |
0.9 | 29 | 28 | 96.6 a |
1.0 | 25 | 24 | 96.0 a |
1.1 | 23 | 22 | 95.7 a |
Significant at p < 0.05.0.1 mmol/L was the first percentage more than 85% at p < 0.05.